Tomoko Okumura (Tomoko Asatsuma-Okumura)

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 6

Top Topics

Respiratory Failure

Acute Lymphoblastic Leukemia

Multiple Myeloma

Binding Protein

Top Venues

Nature chemical biology

European journal of immunology

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Masaaki Hashiguchi, Tomoko Okumura, Yoshiko Iwai
Interleukin 21 promotes IgG1 + plasma cell differentiation instead of class switching to IgE via Blimp1 expression. European journal of immunology (2024)
Masaaki Hashiguchi, Tomoko Okumura, Yoshiko Iwai
Interleukin 21 promotes IgG1 + plasma cell differentiation instead of class switching to IgE via Blimp1 expression. European journal of immunology 54 (8) (2024)
Nobuyuki Shimizu, Tomoko Okumura, Junichi Yamamoto, Yuki Yamaguchi, Hiroshi Handa, Takumi Ito
PLZF and its fusion proteins are pomalidomide-dependent CRBN neosubstrates. Communications biology 4 (1) (2021)
Tomoko Okumura, Takumi Ito, Hiroshi Handa
Molecular Mechanisms of the Teratogenic Effects of Thalidomide. Pharmaceuticals (Basel, Switzerland) 13 (5) (2020)
Junichi Yamamoto, Tetsufumi Suwa, Yuki Murase, Shumpei Tateno, Hirotaka Mizutome, Tomoko Okumura, Nobuyuki Shimizu, Tsutomu Kishi, Shuji Momose, Masahiro Kizaki, Takumi Ito, Yuki Yamaguchi, Hiroshi Handa
ARID2 is a pomalidomide-dependent CRL4CRBN substrate in multiple myeloma cells. Nature chemical biology 16 (11) (2020)
Tomoko Okumura, Hideki Ando, Marco De Simone, Junichi Yamamoto, Tomomi Sato, Nobuyuki Shimizu, Kazuhide Asakawa, Yuki Yamaguchi, Takumi Ito, Luisa Guerrini, Hiroshi Handa
p63 is a cereblon substrate involved in thalidomide teratogenicity. Nature chemical biology 15 (11) (2019)
Shogo Katsura, Tomoko Okumura, Ryo Ito, Akira Sugawara, Atsushi Yokoyama
Identification of Posttranslational Modifications in Peroxisome Proliferator-Activated Receptor γ Using Mass Spectrometry. PPAR research 2014 (2014)